English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Matthias Lutolf is the scientific director of the Roche Institute for Translational Bioengineering and a full professor at the Institutes of Bioengineering and of Chemical Sciences and Engineering at École Polytechnique Fédérale de Lausanne (EPFL). He uses cutting-edge bioengineering strategies for guiding stem cell-based development for the assembly of next-generation organoids with improved reproducibility and physiological relevance.

Matthias Lutolf, interviewed by Peter Loskill (Vice-Chair of EUROoC, the European-Organ-on-Chip-Society)